The pioneering immuno-oncology treatment OPDIVO expanded its portfolio with the introduction of a subcutaneous option. While the story to be told was simple, the launch was a relentless sprint and heavy lift. Developed full menu of tactics for both HCP and clinical nurse teams available for use on Day 1.